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Abstract 
Background: The pathogenic potential of Candida albicans depends on adhesion 
to the host cells mediated by highly glycosylated adhesins, hyphae formation 
and growth of biofilm. These factors require effective N-glycosylation of 
proteins.  
Here, we present consequences of up- and down- regulation of the newly 
identified ALG13 gene encoding N-acetylglucosaminyl transferase, a potential 
member of the Alg7p/Alg13p/Alg14p complex catalyzing the first two initial 
reactions in the N-glycosylation process.  
Methods: We constructed C. albicans strain alg13∆::hisG/TRp-ALG13 with one 
allele of ALG13 disrupted and the other under the control of a regulatable 
promoter, TRp. Gene expression and enzyme activity were measured using RT-
qPCR and radioactive substrate. Cell wall composition was estimated by HPLC 
DIONEX. Protein glycosylation status was analyzed by electrophoresis of 
HexNAcase, a model N-glycosylated protein in C. albicans. 
Results: Both decreased and elevated expression of ALG13 changed expression 
of all members of the complex and resulted in a decreased activity of Alg7p and 
Alg13p and under-glycosylation of HexNAcase. The alg13 strain was also 
defective in hyphae formation and growth of biofilm. These defects could result 
from altered expression of genes encoding adhesins and from changes in the 
carbohydrate content of the cell wall of the mutant.  
General significance: This work confirms the important role of protein N-
glycosylation in the pathogenic potential of C. albicans.  
Keywords Candida albicans, N-glycosylation, Alg13 N-acetylglucosaminyl 
transferase, morphogenesis  
1. Introduction 
Candida albicans is a common component of human microflora and the most 
common cause of opportunistic fungal infections of immunocompromised 
patients, with a mortality rate around 30-50% [1, 2]. The pathogenic potential of 
C. albicans is attributed to several factors including expression of adhesins, the 
yeast-to-hyphae transition and biofilm formation. All these factors can be 
affected by changes in glycosylation of proteins which therefore plays an 
important role in Candida virulence [3, 4, 5, 6].  
N-glycosylation is an essential protein modification highly conserved in 
evolution. In all eukaryotes, N-glycosylation is obligatory for viability since 
glycans have a common role in promoting protein folding, quality control, and 
certain sorting events and, finally, determination of protein activity [7, 8]. N-
glycosylation can be divided into two phases: the first is the assembling of the 
core polysaccharide containing 14 monosaccharide residues which is then 
transferred en bloc to a growing polypeptide chain. The second step of N-
glycosylation is further processing of the polycarbohydrate N-linked to the 
protein to the mature structures characteristic for the host [2, 9-13].  
Glycosylation requires a phosphorylated isoprenoid lipid, dolichyl phosphate 
(Dol-P), as a carrier of the carbohydrates. During N-glycosylation the whole 
core polysaccharide is assembled on Dol-P [10]. Biosynthesis of the lipid-linked 
oligosaccharide (LLO) begins at the cytosolic side of the endoplasmic reticulum 
(ER) with a sequential addition of two N-acetylglucosamine (GlcNAc) residues 
and five mannoses to Dol-P with nucleotide diphosphate sugars, UDP-GlcNAc 
and GDP-mannose,  as donors [14]. The resulting oligosaccharide,  
Dol-PP-GlcNAc2 Man5, is then flipped to the lumen of the ER and four 
mannosyl and three glucosyl residues from Dol-P-mannose and Dol-P-glucose 
are added to form Dol-PP-GlcNAc2 Man9 Glc3. The assembled core 
oligosaccharide is transferred to the γ-amido group of asparagine residues 
located in a highly conserved motif Asn-X-Ser/Thr (X can be any amino acid 
except proline) of the modified protein.  
The addition of the second GlcNAc residue to Dol-PP- GlcNAc is catalyzed by 
a hetero-oligomeric GlcNAc transferase that in most eukaryotes comprises the 
Alg13p and Alg14p subunits. Alg13p is the catalytic subunit recruited to the ER 
by the membrane protein Alg14p [15-17]. Bickel et al. [15] have demonstrated 
that yeast membranes depleted of Alg13p or Alg14p lack GlcNAc transferase 
activity in vitro and accumulate Dol-PP-GlcNAc in vivo. This activity is also 
present in bacteria, however, in E.coli the GlcNAc transferase (MurG) 
catalyzing peptidoglycan biosynthesis is a single protein with Alg13/Alg14 
homologous domains. A structural comparison of Alg13p, Alg14p and MurGp 
based on the crystal structure of the latter has revealed that Alg13p corresponds 
to the C-terminal part of MurG thought to bind the UDP-GlcNAc donor, and 
Alg14p to the N-terminal part containing a glycine-rich motif postulated to be a 
membrane association site involved in Dol-P recognition [18]. The interaction 
between the two Alg13p/Alg14p subunits of UDP-GlcNAc transferase in yeast 
is limited to a C-terminal α-helix (comprised of fifteen amino acids) of Alg13p 
and three amino acids of Alg14p [16, 17, 19]. Furthermore, the N-terminal 
region of Alg14p interacts directly with one more protein, Alg7p. This 
enzymatic protein catalyzes the formation of Dol-PP-GlcNAc, the acceptor of 
the second GlcNAc added by Alg13p [17, 20]. Thus in S. cerevisiae Alg7p is, in 
fact, the third member of the Alg7p/Alg13p/Alg14p (Alg7/13/14) complex 
indispensable for the initial reaction in LLO biosynthesis. The genes coding for 
the proteins forming this complex are essential.  
Here, we cloned and analyzed a previously uncharacterized orf19.6025 from C. 
albicans. This ORF was found by searching a C. albicans genomic data base 
with the Alg13p sequence from S. cerevisiae as probe.  
To analyze the function of this hypothetical Alg13 protein we constructed a C. 
albicans strain alg13∆::hisG/TRp-ALG13 with one allele of ALG13 disrupted 
and the other under the control of a regulatable promoter, TRp. TRp is a strong 
promoter which can be repressed by doxycycline. Thus, depending on the 
composition of medium the constructed strain expressed ALG13 at a level 
exceeding that of the wild type (without doxycycline added) or markedly lower 
(with doxycycline).   
The changes in expression of ALG13 influenced the expression of ALG7 and 
ALG14 and altered Alg7p and Alg13p activities causing under-N-glycosylation 
of the model N-glycosylated protein HexNAcase.   
The impaired glycosylation resulted in defects in hyphae formation and biofilm 
growth- the two invasive forms of Candida. The background of these changes 
included altered expression of HWP1 (hyphae wall protein) and ALS1 
(agglutinin-like sequence protein) genes encoding factors contributing to biofilm 
formation. Changes in the cell wall composition and in the composition of the 
extracellular matrix of biofilm were also observed.  
 
2. Materials and methods 
2.1.  Strains and growth conditions 
C. albicans strain CAI4 (genotype: ura3 ∆::imm434/ ura3 ∆::imm434), an 
uridine auxotroph was used for deletion of ALG13 gene (Table 1).  
E. coli strain DH5α F’ (genotype: F’ supE44 ∆lacU169 {ɸ80 lacZ ∆M15} 
hsdR17 recA1 endA1 ngyrA96 thi-1 relA1) [21] was used for plasmid 
propagation.  
C. albicans strains were routinely grown at 30
o
 C in YPD medium (1% yeast 
extract, 1% Bacto-peptone, 2% glucose) or SD medium (0.67% yeast nitrogen 
base, 2% glucose). Uridine auxotrophic strains were grown on media 
supplemented with uridine (20 µg/ml). To repress the tetracycline promoter, 
doxycycline was added to the medium at concentrations from10 to100 µg/ml; 40 
µg/ml was established as the optimal concentration and was then used 
throughout the study.  
The ability to form hyphae was tested on Spider medium (1% nutrient broth, 1% 
mannitol, 0.2% K2HPO4 and 1.35% agar), YPSerum (1% yeast extract, 0.5% 
peptone, 10% horse serum and 2% agar) or YPD [22].  
For sensitivity assays solid YPD medium (1.5% agar) was supplemented with 
uridine (20 µg/ml), doxycycline (40 µg/ml), tunicamycin (1, 1.5, 2 µg/ml) or 
Congo Red (5, 10, 15 µg/ml) or Calcofluor White (5, 10, 15 µg/ml). To induce 
the excision of URA3 gene, C. albicans transformants were grown on FOA 
plates (0.67% yeast nitrogen base, 2% glucose, 0.3% 5-fluoroorotic acid, 40 
μg/ml uridine, 2% agar).  
 
2.2. Construction of C. albicans strain 
One copy of ALG13 (orf19.6025) was deleted using the “URA-Blaster” method 
[23]. For the construction of the deletion cassette the following primers were 
used: ALG13-flank1-F/ALG13-flank1-R for amplification of the 5’ region of 
homology (-494 to -46 upstream of the ORF) and ALG13-flank2-
F/ALG13flank2-R for amplification of the 3’ region of homology (+3 to +425 
downstream of the AUG start codon) (Table 2). The obtained fragments were 
cloned to the p5921 plasmid in the SacI/BglII and BamHI/SalI sites, 
respectively. The SacI/SalI fragment was then excised and used for gene 
replacement in the CAI4 strain to obtain the alg13∆::hisG-URA3-hisG/ALG13 
strain. The URA3 selective marker was removed as above to obtain the 
alg13∆:hisG /ALG13 hemizygote [23].  
To put the second copy of ALG13 under the control of tetracycline  promoter 
(TRp), primers ALG13-TRp-F and ALG13-TRp-R were used to amplify the 
cassette on the template of p2151c plasmid. The 4067-bp fragment contained: a 
55-bp fragment homologous to region -162 to -107 bp upstream of the ALG13 
start codon,  the URA3 selection marker, the fusion transactivator – tetR-
ScHAP4AD, the regulatable tetO-ScHOP1 promoter and a 53-bp sequence 
homologous to region -4 to +49 bp of ALG13. The cassette was used for 
transformation of the alg13∆::hisG/ALG13 strain.  
Proper construction of the strains was confirmed by Southern blot analysis 
(Fig.1S). DNA was isolated from the alg13∆::hisG/ALG13, alg13∆::hisG/TRp-
ALG13 and the CAI4 control strain, digested with BanI, BglII, or HindIII, 
electrophoresed, transferred to Hybond-N membrane and hybridized with a 
DIG-labelled 445-bp probe homologous to the coding region of ALG13.  The 
probe was amplified by PCR with ALG13-flank2-F and ALG13-flank2-R 
primers on C. albicans genomic DNA and visualized with the NBT/BCIP 
system (Promega).   
 
2.3. Molecular biology methods 
Chromosomal DNA was isolated from C. albicans using the Promega Wizard 
Genomic DNA Purification kit. Total RNA was isolated using the single-step 
method described by Chomczynski and Sacchi [24]. Other molecular biology 
procedures were performed according to standard protocols [25]. 
 2.4. Quantitative reverse transcription PCR (RT-qPCR) 
Reverse transcription was performed using the Advantage RT-for-PCR Kit 
(Clontech Laboratories) with 1 µg of total RNA as a template. Gene-specific 
primers designed using Clone Manager 6 software, their calculated Tm and 
amplicon sizes are shown in Table 3. qPCR assays were performed in a Light 
Cycler 1.6 Instrument (Roche Life Science). For the amplification Light Cycler 
Fast Start DNA Master PLUS SYBR Green (Roche Life Science) mix was 
combined with 0.2 µM forward and reverse primers and cDNA diluted 1:5 with 
nuclease-free water. The thermal cycling conditions were as follows: initial 
denaturation at 95
o
 C for 10 min, followed by 40 cycles of denaturation at 95
o
 C 
for 10 s, annealing at appropriate temperature (Table 3) for 10 s and elongation 
at 72
o
 C for 1s per 25 bp. All primer pairs produced a single amplicon with a 
uniform melting curve as determined by the denaturation profile of the product. 
Two technical repeats were carried out for each data point. The expression ratios 
of the investigated transcripts were calculated against actin as a reference gene 
using Pair Wise Fixed Reallocation Randomization Test © and Relative 
Expression Software Tool REST ©. Each assay was repeated three times for 
independently isolated RNA. 
 
2.5. Cell membrane preparation  
C. albicans strains were cultured at 30
o
C in 1 l of YPD medium to OD600=1-1.5; 
the cells were then harvested by centrifugation and resuspended in 2 volumes of 
50 mM Tris/HCl buffer pH 7.4 containing 15 mM MgCl2 and 9 mM 2-
mercaptoethanol. The suspension was homogenized with 0.5-mm glass beads 
and the homogenate was centrifuged at 4 000 x g for 10 min to remove 
unbroken cells and cell debris. The supernatant was centrifuged for 1 h at 50 000 
x g and the pelleted membrane fraction was used for enzymatic assay.  
 
2.6. Determination of N-acetylglucosaminyl transferase (Alg7p and Alg13p) 
activities 
Formation of Dol-PP-GlcNAc and Dol-PP-GlcNAc2 was measured in the 
membrane fraction by incubation for 30 min at 30
o
C of 200 µg of membrane 
proteins in a total volume of 50 µl containing: 1 x 105 cpm UDP[14C]N-
acetylglucosamine (sp. act.: 300 mCi/mmol, American Radiolabeled Chemicals, 
Inc.) and 5 ng of Dol-P in 40 mM Tris/HCl buffer pH 7.4 with 10 mM MgCl2 
and 0.1% Nonidet P-40 [26, 27]. The reaction was stopped by addition of 4 ml 
of chloroform – methanol (3:2 v/v). After removing the denatured protein by 
centrifugation, the lipid phase (supernatant) was washed and the radioactive 
glycolipids were separated by TLC chromatography on silica gel 60 plates 
(Merck) in chloroform: methanol: water (65:25:4 v/v/v). Radioactive Dol-PP-
GlcNAc and Dol-PP-GlcNAc2 spots were located by autoradiography, scraped 
off the plates and their radioactivity was determined in a scintillation counter. 
 To analyze separately the activity of Alg7 or Alg13, the enzymes were 
solubilized as described [28,29]: membrane preparation (6 mg/ml proteins) was 
incubated in 1.25 M sodium chloride, 0.5 mM dithiothreitol, 20% glycerol and 6 
mM diheptanoylphosphatidylcholine for 20 min on ice and centrifuged for 40 
min at 160 000 x g.  
To analyze the formation of Dol-PP-GlcNAc the reaction contained in a final 
volume of 60 µl: 28 mM Tris/HCl, pH 7.4, 20 mM MgCl2, 0.7 mM DTT, 0.3% 
Nonidet P-40, 23% glycerol, 3.5 mM diheptanoylphosphatidylcholine, 0.7 M 
NaCl, 1 x 10
5
 cpm UDP[
14
C]N-acetylglucosamine, 2 μg Dol-P and solubilized 
enzyme (equivalent to 0.2 mg membrane protein). After incubation for 3 min at 
30
o
C the reaction was stopped by addition of 4 ml of chloroform – methanol 
(3:2 v/v) and processed as above.  
To analyze the formation of Dol-PP-GlcNAc2 the reaction contained in a final 
volume of 60 µl: 27 mM Tris/HCl, pH 7.5, 10 mM MgCl2, 0.8 mM DTT, 0.45% 
Nonidet P-40, 27% glycerol, 0.2 mM UDP-GlcNAc, Dol-PP- [
14
C] GlcNAc- 
(3000 cpm) and solubilized enzyme (equivalent to 0.1 mg membrane 
protein). After incubation for 6 min at 30
o
C the reaction was stopped and 
processed as above.   
  
2.7. Determination of cis-prenyltransferase activity 
The enzyme activity was assayed in the membrane fraction by incubation for 90 
min at 30
o
 C of 100 g of membrane proteins with 4 g of farnesyl diphosphate 
(FPP), 50 mM sodium phosphate buffer pH 7.4, 0.5 mM MgCl2, 20 mM 2-
mercaptoethanol, 10 mM KF and 3 x 10
5
 cpm [
14
C] isopentenyl diphosphate 
(IPP) (sp. act.: 55 mCi/mmol, American Radiolabeled Chemicals, Inc.) (final 
volume 50 l). The reaction was terminated by addition of 4 ml of chloroform - 
methanol (3: 2 v/v). The protein pellet was removed by centrifugation and the 
supernatant was washed three times with 1/5 volume of 10 mM EDTA in 0.9 % 
NaCl. The organic phase was concentrated under a stream of nitrogen and 
subjected to thin-layer chromatography on HPTLC RP-18 plates developed in 
50 mM H3PO4 in acetone. The zone containing the radiolabeled polyprenols was 
scraped off and the radioactivity was measured in a scintillation counter [30]. 
 
2.8. Immunodetection of Alg7 protein 
Total membrane fraction use for activity assay was also examined for the 
amount of the Alg7 protein by immunostaining with monoclonal antibody 
against human Alg7p (OriGene, Herford, Germany). Membrane proteins were 
solubilized in 0.1% Nonidet P40, subjected to the Immobilon P membrane 
(Milipore) and C.albicans Alg7 protein was detected by immunological reaction 
with human antibody. Immunoreactive material was detected using an anti-
mouse IgG secondary antibody conjugated to alkaline phosphatase (Sigma-
Aldrich). Bovine serum albumin was used as a negative control.  
 2.9. Determination of N-acetylglucosaminidase (HexNAcase) activity in situ 
The HexNAcase in situ activity staining was performed as described [3]. To 
induce HexNAcase production strains were grown for 16 h in SC medium 
supplemented with 25 mM N-acetylglucosamine (GlcNAc) in the presence or 
absence of doxycycline. Cells were disrupted by vortexing with glass beads in 
10 mM Tris/HCl, pH 8, containing protease inhibitor cocktail (Sigma-Aldrich). 
After lysate clarification by centrifugation, samples were mixed with native 
loading dye and run on a Tris/acetate 3–8% gradient polyacrylamide gel 
(Invitrogen) under non-denaturing conditions. The gel was washed in 0.1 M 
citrate/KOH buffer, pH 4, for 10 min at room temperature and then incubated in 
substrate solution (0.18 mM naphthyl-GlcNAc (Glyco-synth Ltd., Warrington, 
UK) in 0.1 M citrate/KOH buffer, pH 4) for 30 min at 37
o
C. The reaction was 
visualized by incubation in the substrate solution plus 0.7 mM Fast Blue at 60
o
C 
until the color developed. 
 
2.10. Cell wall preparation  
C. albicans was cultivated in YPD medium, washed with 10 mM Tris/HCl, pH 
7.5, suspended in the same buffer, disintegrated with 0.5 mm glass beads in the 
presence of a protease inhibitor coctail (Sigma-Aldrich) and centrifuged at 1500 
x g for 10 min. The resulting pellet containing cell walls was washed with ice-
cold 1 M NaCl until disappearance of absorbance at 260-280 nm [31].   
For the cell wall analysis during biofilm growth, biofilm was cultivated for 12 h, 
cells were scraped from the surface and used for cell wall preparation.  
 
2.11. Determination of  cell wall carbohydrates 
Lyophilized cell wall was hydrolyzed o/n in 4 M trifluoroacetic acid (TFA) at 
100
o
 C. After cooling on ice, samples were centrifuged at 17 000 x g for 5 min at 
4
o
 C. The supernatant was dried under N2 and washed twice with pure methanol. 
After removing methanol with N2, the pellet was resuspended in miliQ water 
and purified on a Millipore Filter Device (0.45 µm pores) by centrifugation at 16 
000 x g for 4 min. Samples were stored at -20
o
 C. Monosaccharides were 
determined by high performance anion-exchange chromatography using a 
Dionex ICS-3000 Ion Chromatography System with a Carbo Pac PA10 
analytical column. Neutral sugars were eluted with 18 mM NaOH at 0.25 
ml/min [32].  
 
2.12. Biofilm formation  
C. albicans biofilm development was documented under a light microscope [33-
35].  
Strains were grown for 16 h at 30
o
C in liquid YPD medium supplemented with 
20 µg/ml of uridine (if necessary), centrifuged and the cell pellet was 
resuspended in YPD with 20 µg/ml of uridine and 40 µg/ml of doxycycline (if 
necessary) and adjusted by measuring optical density at 600 nm to a final 
concentration of 1 x 10
6
 cells per ml. Three-milliliter portions of the 
standardized cell suspension were transferred into sterile 55-mm Petri dishes and 
incubated at 37
o
C for 1.5, 6, 12, and 48 h. Subsequently, non-adhered cells were 
washed away from the biofilm with two 2-ml portions of phosphate buffered 
saline (PBS) and the biofilm was allowed to dry and examined under a light 
microscope (Delta Optical). The assay was carried out in triplicate for each 
strain.   
 
2.13. Isolation of extracellular DNA (eDNA) from biofilm cultures  
Strains were cultivated for biofilm formation for 12 h. Culture medium was 
decanted and the biofilm was washed twice with 5 ml of water. The liquids were 
pooled, centrifuged to remove cell debris and dialyzed o/n at 4
o
C against 2 l of 
water and lyophilized. Ten milligrams of the resultant powder was dissolved in 
0.5 ml of water, extracted with phenol: chloroform: isoamyl alcohol (25:24:1, 
v/v/v) and eDNA was then precipitated with isopropanol. The eDNA was 
dissolved in 20 µl of water and analyzed using a Colibri Microvolume 
Spectrophotometer (Bertold Titertek).   
 
2.14. Isolation of extracellular glucan from biofilm cultures 
The same powder which was used for eDNA preparation was also analyzed for 
extracellular glucan. Ten milligrams of the powder was hydrolyzed o/n in 4 M 
TFA at 100
o
 C and analyzed as described for the cell wall carbohydrate analysis.  
  
3. Results 
3.1. Disruption of putative ALG13 gene in C. albicans 
The aim of this study was to find a homologous gene in C. albicans and to 
characterize its function. A putative ALG13 gene (orf19.6025) was found in the 
genomic data base of C. albicans (http://www.candidagenome.org/) using the 
amino acid sequence of Alg13 protein from S. cerevisiae as probe. The 879-bp 
orf19.6025 potentially encoded a protein of 293 amino acids, a predicted 
catalytic subunit of N-acetylglucosaminyldiphosphodolichol: N-
acetylglucosaminyltransferase Alg13p (GlcNAc-T) [EC 2.4.1.141] from  
C. albicans. This hypothetical protein showed 37% identity with the 202-amino 
acid Alg13p from S. cerevisiae (E value 8e-32) (Fig.1). We also found a 
sequence potentially encoding a homologue of the S. cerevisiae Alg14p anchor 
protein. The identity between these proteins from S. cerevisiae and C. albicans 
was  32% (E value 7e-30).   
To confirm the function of the predicted Alg13p in C. albicans one copy of 
orf19.6025 was disrupted and the second one was put under the control of the  
regulatory tetracycline promoter TRp (see Materials and methods). These 
changes made in the CAI4 genome were confirmed by Southern blot analysis 
(Fig.1S). DNA from strains alg13∆::hisG/ALG13, alg13∆::hisG/TRp-ALG13 
and the control strain CAI4 was cut with BanI, BglII or HindIII restriction 
enzymes (not cutting inside the ALG13 gene) and hybridized with a 445-bp 
DNA probe homologous to the orf19.6025 coding region. The analysis using 
BanI revealed two hybridizing bands in the wild type strain CAI4, suggesting 
that the two orf19.6025 copies are localized differently in the homologous pair 
of chromosomes or that a BanI restriction site is mutated in one of the 
chromosomes. To elucidate this finding we cut the genomic DNA with BglII or 
HindIII. Both enzymes gave a single hybridizing band which proved that the 
localization of the ALG13 gene was the same in both chromosomes. Thus a BanI 
restriction site close to orf19.6025 had to be absent in one copy of the genome. 
This finding was not surprising since a particularly high variability of the 
upstream regions of genes has been reported for C. albicans [36].   
 
3.2. Expression of orf19.6025 and its effect on UDP-N-
acetylglucosaminyl:DolPP-N-acetylglucosaminyl transferase [EC 2.4.1.141] 
activity 
To quantify orf19.6025 expression in the wild type and the mutant strain total 
RNA was isolated and reverse transcription qPCR analysis was performed. A 
significant reduction of orf19.6025 expression was observed in the 
alg13∆::hisG/TRp-ALG13 strain cultivated with doxycycline. Consequently, 
cultivation without doxycycline, when the TRp promoter was fully active, 
resulted in an uncontrolled expression exceeding over eight-fold the expression 
in the CAI4 wild type control strain (Fig.2).  
Since the activity of UDP-N-acetylglucosaminyl:DolPP-N-acetylglucosaminyl 
transferase depends on the proper localization of the Alg13p catalytic subunit of 
the enzyme in the ER we examined expression of orf19.5363, a putative ALG14 
gene coding for the protein anchoring Alg13p in the ER.  
Expression of ALG14 was decreased by the uncontrolled high expression of 
ALG13 gene in the alg13∆::hisG/TRp-ALG13 strain cultivated without 
doxycycline. In the alg13∆::hisG/TRp-ALG13 strain cultivated with doxycycline 
expression of ALG14 was the same as in the control strain.  
To gain a complete picture of the expression of all components of the N-
acetylglucosaminyl transferase complex we also examined expression of 
orf19.2187 encoding Alg7p [EC.2.7.8.15] [37]. Expression of ALG7 was 
decreased in the alg13∆::hisG/TRpALG13 strain irrespective of the cultivation 
conditions (Fig.2).  Lower expression of ALG7 resulted in lower amount of Alg7 
protein in the membrane fraction of the alg13∆::hisG/TRpALG13 mutant 
compared to the control strain (Fig.3).   
Next, we examined how the changes in the expression of ALG7, ALG13 and 
ALG14 influenced the rates of formation of Dol-PP-GlcNAc and Dol-PP-
GlcNAc2, products of the activity of Alg7p and Alg13p N-acetylglucosaminyl 
transferases, respectively. The decreased expression of ALG7 combined with the 
increased expression of ALG13 in the alg13∆::hisG/TRpALG13 strain cultivated 
without doxycycline resulted in a production of Dol-PP-GlcNAc 36% lower 
than in the control (Fig.4A). A further decrease of Dol-PP-GlcNAc formation by 
65% was observed when the alg13∆::hisG/TRpALG13 strain was cultivated 
with doxycycline.  
The presence of doxycycline in the cultivation medium of the 
alg13∆::hisG/TRpALG13 strain resulted in a significant decrease of combined 
Alg7p and Alg13p activity (as measured by the formation of Dol-PP-GlcNAc2) 
by 84% compared to the control, while without doxycycline this activity was 
lower by 55% than in the control strain (Fig.2, 4A).  
Those activity assays performed in the membrane fraction showed how these 
enzymes worked in the enzymatic complex when the amount of substrate for 
Alg13p was limited by Alg7p activity and the Alg7p product was consumed by 
the action of Alg13p. To avoid this limitation we liberated both enzymes from 
the membrane fraction and analyzed their activity separately. The decreased 
expression of ALG7 and decreased amount of Alg7 protein in the mutant strain 
cultivated without doxycycline resulted in a 74% lower activity of Alg7p 
compared to the control strain and 80% lower when doxycycline was added 
(Fig.2, 3, 4B).  
The activity of Alg13p was nearly the same in the mutant strain in both 
cultivation conditions as in the control.  
 
3.3. Cis-prenyltransferase (cis-PT) activity 
The Alg7p N-acetylglucosaminyl transferase requires dolichyl phosphate (Dol-
P) as the acceptor of the carbohydrate residue, therefore the amount of Dol-P 
available affects the velocity of the Alg7p-catalyzed reaction, and, consequently, 
also that catalyzed by Alg13p. Dolichol is synthesized by cis-prenyltransferase 
(cis-PT) which uses monomers synthesized via the mevalonate pathway. To 
establish the possible regulatory role of the availability of the Dol-P acceptor for 
the reaction catalyzed by Alg7p we measured the activity of cis-PT in the 
studied strains and found it was decreased in the mutant. The lowest activity was 
observed for the alg13∆::hisG/TRpALG13 strain cultivated without doxycycline 
(Fig.5).  
 
3.4. Defective Alg13p activity results in under-N-glycosylation of proteins 
A lower activity of Alg13p should result in defects in protein glycosylation. To 
verify this assumption we analyzed in the alg13 strain the in situ activity of 
HexNAcase, which had previously been used to gauge protein glycosylation 
level in C. albicans [3, 38]. C. albicans was cultivated in a medium containing 
GlcNAc as the sole carbon source to induce HexNAcase production. Cell 
extracts were then run in a native gel, incubated with an artificial substrate 
(naphthyl-GlcNAc) and with tetrazolium salt for visualization. The mobility of 
HexNAcase on the gel should be increased by defective glycosylation. Indeed, 
the enzyme from the mutated strain displayed an increased electrophoretic 
mobility compared to that from the control strain CAI4, the most pronounced 
glycosylation defect being revealed for HexNAcase from the 
alg13∆::hisG/TRpALG13 strain cultivated with doxycycline (Fig.6). Thus, the 
lower activity of Alg13p resulted in under-glycosylation of proteins, as 
expected.  
 
3.5. Sensitivity to tunicamycin 
Tunicamycin specifically inhibits the activity of Alg7p [39]. Since the activity of 
Alg7p was inhibited to various extents in the alg13∆::hisG/TRpALG13 strain 
cultivated in the presence or without doxycycline, different sensitivity of this 
strain to tunicamycin could be expected. In the presence of tunicamycin growth 
of the control strain was partially inhibited while the alg13∆::hisG/TRpALG13 
strain could not grow regardless of the doxycycline presence in the medium 
(Fig.7). Notably, addition of doxycycline to the medium partially inhibited 
growth of the alg13∆::hisG/TRpALG13 strain even in the absence of 
tunicamycin.  
 
3.6. Defective activity of Alg13 alters morphology of C. albicans 
C. albicans can grow in the unicellular form but also as pseudohyphae and true 
hyphae. It has previously been shown that C. albicans mutated in DPM synthase 
subunits cannot grow in the filamentous (hyphal) form [40]. Since Alg13p, 
similarly as DPM synthase [10, 41], is required for N-glycosylation we checked 
the influence of Alg13p depletion for hyphae formation. The mutant and the 
control strain were cultivated on horse serum medium (YPSerum), Spider 
medium and on YPD medium. As presented in Fig. 7 the CAI4 wild type strain 
formed filaments on Spider medium and YPSerum while the 
alg13∆::hisG/TRpALG13strain was unable to assume  filamentous form with or 
without doxycycline in the medium. In contrast, all the strains formed filaments 
on YPD medium, although they were less frequent for  
alg13∆::hisG/TRpALG13, especially when it was cultivated with doxycycline 
(Fig.8).   
 
3.7. Defective activity of Alg13p alters biofilm formation  
Studies of Candida morphology indicate that filamentous growth is required for 
stable biofilm formation [42]. Since the alg13 strain revealed defects in 
filamentation (Fig.9), we studied its ability to form biofilm.  
Following cultivation on Petri dishes as described in Methods, non-adherent 
cells were washed away and the biofilm left was examined under a light 
microscope. Our analysis revealed that CAI4 needed 6 h to start forming the 
biofilm while the alg13∆::hisG/TRpALG13 strain cultivated without 
doxycycline required more than 12 h (Fig.9). With doxycycline biofilm 
formation took at least 48 h and still the biofilm did not overgrow the whole 
surface of the plate.  
The adhesion of Candida cells to synthetic materials has been shown to be  
preceded by expression of adherence molecules, such as agglutinin-like proteins 
(Als), hyphal wall proteins (Hwp) and cell wall glycoproteins [43-46].  
Since we observed delayed biofilm formation, expression of ALS1 and HWP1 
genes was analyzed in our strains after 6, 12 and 48 h of cultivation.  
Expression of ALS1 was significantly lower in the alg13∆::hisG/TRp-
ALG13strain after 6 h of biofilm formation with or without doxycycline 
compared to the control strain (Fig.10). After 12 h the expression in the 
alg13∆::hisG/TRp-ALG13strain cultivated without doxycycline was similar to 
the control while during cultivation with doxycycline it remained slightly lower. 
After 48 h of  biofilm cultivation ALS1 expression was undetectable in all the 
strains.  
Expression of HWP1 showed a strikingly different pattern. In in 
alg13∆::hisG/TRp-ALG13strain cultivated without doxycycline it was ca. 1.5-
fold higher than in the control during the first 12 hours and increased even 
further after 48 h of biofilm cultivation. Repression of ALG13 gene by 
doxycycline reduced the expression of HWP1 to ca. half of the control value 
throughout biofilm cultivation.  
The C. albicans biofilm has a highly heterogeneous structure in which adherent 
cells are covered by extracellular matrix [42] containing extracellular DNA 
(eDNA), proteins and polysaccharides [47-49].  
We studied the content of those components in the biofilm matrix of the C. 
albicans strains. After 12 h of biofilm formation its surface was rinsed to 
remove non-adherent cells and extracellular material, the suspension was 
centrifuged and supernatant was used for eDNA and glucan quantification. The 
eDNA content in the extracellular material of the alg13∆::hisG/TRp-ALG13 
strain cultivated with or without doxycycline was, respectively, twice and 1.7 
times that of the wild-type strain (Fig.11A).  
The extracellular glucan content, determined as glucose following hydrolysis, 
was also elevated in the alg13∆::hisG/TRp-ALG13strain – by 45% and 22%, 
respectively, with and without doxycycline compared to the control strain 
(Fig.11B).   
 
3.8. Defective activity of Alg13p influences cell wall structure 
The C. albicans cell wall composition is similar to that of S. cerevisiae and 
contains four classes of interacting components: chitin, β1,3 and β1,6 glucan, 
and highly glycosylated mannoproteins [50,51].  
To establish the influence of a decreased activity of Alg13p on the cell wall 
composition it was isolated from the C. albicans strains and subjected to acidic 
hydrolysis and the monocarbohydrate content was analyzed. The 
alg13∆::hisG/TRp-ALG13 strain cultivated with or without doxycycline had a 
lower concentration of mannose in the cell wall compared to the control strain 
(Fig.12). The lowest mannose content, 49% of that in the control, was found in 
the cell wall of alg13∆::hisG/TRp-ALG13 strain cultivated with doxycycline.  
The amount of cell wall glucose was similar to that in the control strain. The 
small differences observed for the alg13∆::hisG/TRp-ALG13strain cultivated 
with or without doxycycline were not statistically significant (Fig.12).  
The content of the cell wall N-acetylglucosamine was decreased in the mutant, 
however, only the 50% decrease found for the alg13∆::hisG/TRp-ALG13strain 
cultivated with doxycycline was statistically significant (Fig.12). Under these 
conditions this strain was also hypersensitive to Calcofluor White and Congo 
Red, agents affecting the cell wall integrity (Fig.7).  
The cell wall composition was also analyzed after 12 h of biofilm formation. No 
differences in the glucose or mannose content were found between the control 
and the mutant (supplementary Fig.2S), and the slight decrease of the N-
acetylglucosamine content in the cell wall of the mutant compared to the control 
strain was not statistically significant (supplementary Fig.2S).   
 
4. Discussion  
N-and O-glycosylation of proteins has been demonstrated to be important in the 
host-fungus interaction and for the expression of virulence of Candida [2, 3, 6, 
52, 53].  
In this work we have identified and characterized an essential ALG13 gene from 
C. albicans, encoding Alg13p catalyzing the first step of LLO formation during 
N-glycosylation. We presented consequences of decreased expression and 
overexpression of ALG13 in the heterozygous alg13 strain cultivated, 
respectively, in repressing and derepressing conditions.  
It is known that Alg13p forms an active complex with Alg7p and Alg14p with 
the 1:1:1 stoichiometry [16]. Hetero-oligomerization of the ER 
glycosyltransferases contributes to the efficiency of LLO synthesis. LLO 
intermediates are channeled from one enzyme to the other without diffusion 
[16]. Such an organization results in feedback relationship between the products 
of the reactions catalyzed by Alg7p and Alg13p, where the second intermediate, 
Dol-PP-GlcNAc2,  inhibits the formation of the first, Dol-PP-GlcNAc [55]. In 
our study, cross-regulation of  Alg7p, Alg13p and Alg14p expression and 
activity was also found.  
As expected, an altered expression of ALG13 affected the expression of the two 
other members of the predicted Alg7/13/14 complex. Overexpression of 
ALG13failed to increase activity of Alg13p most likely due to the compensatory 
lower expression and activity of Alg7p and lower expression of ALG14. It was 
shown that overexpression of Alg13p in S. cerevisiae led to its cytosolic 
partitioning, as did reduction of Alg14p level [55]. Potential shortage of Alg14p 
anchor protein during overexpression of ALG13could lead to excess of cytosolic 
Alg13p, whereas only membrane-associated Alg13p was reported to be stable 
[56]. Proteasomal degradation of excess unassembled Alg13p was found as an 
important quality control mechanism that ensured proper Alg7/13/14 complex 
assembly [56].  
A low expression of ALG13 in the regulatory strain cultivated with doxycycline 
where simultaneously expression of both ALG7 and ALG13 genes was decreased 
resulted in a further decrease of enzymatic activity.   
The combined lower activity of the first two enzymes creating LLO limited 
protein N-glycosylation, as was shown for the model enzyme HexNAcase used 
earlier to monitor the N-glycosylation level in Candida [3, 38]. Glycosylation of 
this enzyme decreased with the decreasing activity of Alg13p. This effect was 
enhanced by the lower activity of cis-prenyltransferase in alg13∆::hisG/TRp-
ALG13 strain and the consequently diminished dolichol level additionally 
decreasing the glycosylation [38].  
The compromised protein N-glycosylation affected the pathogenicity attributes 
of C. albicans. It has previously been observed that the cellular processes and 
structures involved in C. albicans pathogenicity are connected with 
glycosylation (reviewed in [1]). They include molecules mediating adhesion to 
the host cell, secretion of hydrolases, and hyphae and biofilm formation [33, 42, 
46, 57-59]. The  adhesion is mediated by adhesins, glycosylphosphatidylinositol 
(GPI)-linked cell surface glycoproteins that are  heavily N- and O-glycosylated 
[60]. C. albicans has a specialized set of adhesins (Als1-7 and Als9) which 
mediate adherence to other cells and to abiotic surface [1, 61]. An increased 
expression of adherence genes is a property of  biofilm-forming cells. Various 
adhesin genes were differentially expressed in C. albicans under different host 
and model conditions [61], probably reflecting the preferential expression of 
only the appropriate, most effective adhesins in any given situation. ALS1 was 
the most upregulated adherence gene of C. albicans under biofilm-inducing 
conditions [62]. In the strains studied here with impaired glycosylation, 
processing of these glycoproteins could be altered. 
Notably, the expression of ALS1 gene was lower in the Alg13-deficient cells 
compared to the control strain. Since biofilm formation is connected with hyphal 
growth we also investigated the expression of HWP1 gene encoding a hyphae-
associated GPI-linked protein, known for its role in host cell attachment and 
biofilm formation [1, 45, 63, 64]. The alg13∆::hisG/TRp-ALG13 strain 
cultivated without doxycycline revealed a gradual increase of HWP1expression 
during 48 h of cultivation. Since a delayed biofilm formation was observed it 
seems likely that this was a consequence of the delayed expression of hyphal 
proteins and thus the formation of hyphae. Cultivation of the alg13∆::hisG/TRp-
ALG13 strain with doxycycline resulted in very low expression of HWP1gene 
coincident with only sporadic production of hyphae. This in turn prevented or 
greatly delayed biofilm formation.  
In this study we demonstrated that both increased and decreased expression of 
ALG13 resulted in filamentation defects. It has been shown that inhibition of the 
first reaction in LLO assembly by tunicamycin alters filamentation and yeast 
bud formation in Candida [65, 66]. Richard et al. [34] have shown that defects 
in hyphae formation hamper retention of cells in the biofilm since hyphae 
provide an adherent scaffold stabilizing the biofilm structure. In our study the 
control strain CAI4 formed filaments independently of the medium (YPSerum, 
Spider medium and YPD) used. In contrast, the residual capacity of the 
alg13∆::hisG/TRp-ALG13 strain to produce filaments could only be revealed on 
the glucose-containing medium YPD. It has been reported [33] that a lack of 
glucose in the cultivation medium limits cells adhesion and biofilm formation, 
both significantly inhibited by the impaired N-glycosylation in the 
alg13∆::hisG/TRp-ALG13 strain.    
Another factor among biofilm stabilizers is the extracellular matrix containing, 
i.a., eDNA and glucan [48, 49]. Our study showed that the alg13∆::hisG/TRp-
ALG13 strain poorly forming biofilm actually released higher amounts of the 
components of the extracellular matrix. eDNA is required for the initial 
attachment as well as for subsequent early phases of biofilm formation in several 
bacterial species, but only for few species the DNA is an important structural 
component of mature biofilms [67]. Since the alg13∆::hisG/TRp-ALG13 strain 
showed a significant delay in biofilm formation, the release of large amounts of 
eDNA and glucan could represent a compensatory reaction necessary for the 
initial establishment of the biofilm.  
The defective N-glycosylation also altered the cell wall composition. In general, 
the Alg13p-deficient strain cultivated in liquid medium contained less mannose 
and N-acetylglucosamine in its cell wall compared to the control strain.  
O- and N-linked mannans, along with β-glucans, represent the main  
C. albicans pathogen-associated molecular patterns recognized by the innate 
immune system. Mannans play important roles in cell wall integrity, adhesion to 
host cells and tissues, virulence, and the establishment of a response by immune 
cells [5, 68].  
On the other hand, during biofilm growth the carbohydrate content was nearly 
the same in the cell wall of the mutant and the control strain. This reflected 
differences in the cell wall composition of the strains growing in the biofilm 
form and in the liquid medium. We observed lower amounts of N-
acetylglucosamine in the strains growing in biofilm conditions compared to the 
liquid cultures and some differences in mannose content. It seems interesting 
that under biofilm inducing conditions the cell wall composition of the surface 
associated cells of all the strains became similar to each other.  
In summary, we showed that C. albicans orf19.6025 identified as homologous to 
S. cerevisiae ALG13 gene encodes an Alg13p N-
acetylglucosaminyldiphosphodolichol: N-acetylglucosaminyltransferase, a 
member of potential Alg7/13/14 complex. Altered expression of this gene 
influenced the expression of the other members of the complex. A decreased 
activity of Alg7p and Alg13p caused under-glycosylation of proteins, 
hypersensitivity to Calcofluor White and Congo Red, changes in cell wall 
composition, hyphae formation and biofilm growth.  
These results confirm the important role of protein N-glycosylation in the 
pathogenic potential of C. albicans.  
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Figures Legend  
Figure 1 
Deduced amino acid sequences of C.albicans Alg13 and Alg14 proteins and 
their alignment with sequences of homologous proteins of S. cerevisiae. 
Potential membrane spanning regions of Candida proteins are indicated by black 
line above the sequence. 
Figure 2 
Transcript levels of ALG7, ALG13 and ALG14 genes determined by RT-qPCR.  
C. albicans strains were grown for 16 h in YPD medium, RNA was extracted 
and cDNA synthesized. alg13∆::hisG/TRpALG13 strain was cultivated in 
repressive (plus doxycycline) or derepressive (without doxycycline) conditions. 
qPCR reactions were performed using a LightCycler 1.6 instrument. The 
crossing point (Cp) value (cycle number in the log-linear region) was calculated 
using the LightCycler quantification software. Data obtained from three 
independent experiments each determined in triplicate.   
Figure 3 
Immunodetection of C. albicans Alg7 protein in the membrane fraction of 
alg13∆::hisG/TRpALG13 strain and the control with human anti-Alg7 protein 
antibody.  
Serial 1:10 dilutions of membrane proteins were applied onto Immobilon P 
membrane.  
CAI4 - control strain,  
alg13∆::hisG/TRpALG13 strain cultivated without (-Dx) or with (+Dx)  
doxycycline  
Figure 4 
Accumulation of products of N-acetylglucosaminyl transferases Alg7 and 
Alg13. 
A - combined enzymatic activity in membrane fraction 
B - individual enzymatic activity after solubilization 
CAI4 - control strain,  
alg13∆::hisG/TRpALG13 strain cultivated without (-Dx) or with (+Dx)  
doxycycline  
Data are mean  standard deviation from three independent experiments each 
determined in triplicate. 
Stars indicate statistically significant differences (P<0.05; t test) 
Figure 5 
Activity of cis-prenyltransferase in membrane fraction.  
CAI4 - control strain,  
alg13∆::hisG/TRpALG13 strain cultivated without (-Dx) or with (+Dx)  
doxycycline  
Data are mean  standard deviation from three independent experiments each 
determined in triplicate. 
Stars indicate statistically significant differences (P<0.05; t test) 
Figure 6  
Activity of HexNAcase in native gel.  
Differences in mobility result from different extents of glycosylation of the 
enzyme. Strains were cultivated in the presence of N-acetylglucosamine to 
induce production of HexNAcase. Fifty micrograms of cell free extract proteins 
was run on native gel. The activity was developed as described in the Methods.   
1- CAI4; 2- alg13∆::hisG/TRpALG13, -Dx; 3 - alg13∆::hisG/TRpALG13, +Dx 
Figure 7 
Effect of ALG13 up- and down-regulation on C. albicans sensitivity to selected 
agents.  
Control strain CAI4 and the alg13∆::hisG/TRpALG13 strain were cultivated 
with or without doxycycline. Serial 1:10 dilutions were plated on YPD plates 
supplemented with tunicamycin, Congo Red or Calcofluor White and cultivated 
at 30
o
C for 72 h.  
Figure 8 
Hyphal growth of C. albicans wild-type strain CAI4 and alg13 strain.  
Hyphae formation was induced for 7 days at 30
o
C on YPSerum, Spider medium  
and YPD medium plates supplemented or not with doxycycline as indicated and 
colonies were photographed under a light microscope.  
Magnification used is indicated on the right. 
Figure 9 
Biofilm formation by C. albicans wild-type strain CAI4 and alg13 strain on 
YPD medium. Three milliliters of cell suspensions (1 x 10
6
 cells per ml) were 
transferred into sterile 5.5-mm Petri dishes and incubated at 37
o
C. Non-adherent 
cells were washed away, biofilm was dried and photographed under a light 
microscope.  
Magnification, x10.  
Figure 10 
Transcript levels of ALS1 and HWP1 genes determined by RT-qPCR.  
Biofilm of the control strain CAI4 and alg13 mutant was grown for 6, 12 and 48 
h on YPD medium, RNA was extracted and cDNA synthesized. 
alg13∆::hisG/TRpALG13 strain was cultivated in repressive (plus doxycycline) 
or derepressive (without doxycycline) conditions. qPCR reactions were 
performed using a LightCycler 1.6 Instrument. The crossing point (Cp) value 
(cycle number in the log-linear region) was calculated using the LightCycler 
quantification software. Data obtained from three independent experiments each 
determined in triplicate.   
Figure 11 
eDNA and glucan content in extracellular matrix of biofilm.   
Culture medium was decanted and the biofilm was washed twice with 5 ml of 
water. The liquids were pooled, centrifuged to remove cell debris, dialyzed 
against water and lyophilized. eDNA was extracted and its content was 
measured spectrophotometrically.  
Extracellular glucan was hydrolyzed and glucose content was determined by 
High Performance Anion-Exchange Chromatography.   
A- eDNA content in matrix  
B- amount of glucose obtained by acidic hydrolysis of extracellular glucan  
Data are mean  standard deviation from three independent experiments each 
determined in triplicate. 
Black star indicates statistically significant differences (P<0.05; t test) 
Figure 12 
Cell wall composition of wild type CAI4 strain and the alg13 strain.  
C. albicans strains were grown in liquid YPD medium supplemented (+Dx) or 
not (-Dx) with doxycycline. Major carbohydrates were determined using High 
Performance Anion-Exchange Chromatography in cell wall preparation 
hydrolyzed with 2 M TFA.  
Glucose (Glc), mannose (Man) and glucosamine (GlcN) content in the cell wall 
Data are mean  standard deviation from three independent experiments each 
determined in triplicate. 
Stars indicate statistically significant differences (P<0.05; t test) 
Figure 1S 
ALG13 organization in C.albicans genomic DNA.  
A-southern blot of ALG13 
BanI, BglII and HindIII digested DNA of the control strain CAI4 (lanes 1,2,3), 
hemizygote alg13∆::hisG/ALG13 (lanes 4,5,6) and the 
alg13∆::hisG/TRpALG13 strain (lanes 7,8,9) 
The length indicated under each band represents a predicted DNA size.  
B-schematic representation of restriction analysis of ALG13 
C-schematic representation of ALG13 under the regulatable promoter  
Figure 2S 
Cell wall composition of biofilm of wild type CAI4 strain and the ALG13 
defective strain.  
C. albicans strains were grown in liquid YPD medium supplemented (+Dx) or 
not (-Dx) with doxycycline. Major carbohydrates were determined using High 
Performance Anion-Exchange Chromatography in cell wall preparation 
hydrolyzed with 2 M TFA.  
glucose (Glc), mannose (Man) and glucosamine (GlcN) content in the cell wall 
Data are mean  standard deviation from three independent experiments each 
determined in triplicate.  
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